CD8A and colorectal carcinoma: By utilizing the extensive chemokine expression profile of MSC, MSC-based immunotherapy actively inflamed tumors with immune effector cells, including macrophages and CD8+ T cells, and showed promising therapeutic effects in CRC (Rooney et al., 2015).